Michael Wilmink, Director at Eupraxia Pharmaceuticals, holds 224.87K shares in Eupraxia Pharmaceuticals (Ticker: TSE:EPRX). Most recently, Michael Wilmink Bought C$1,900 shares of Eupraxia Pharmaceuticals on Sep 12, 2024 for an estimated value of 5.14K.
What is the percentage of profitable transactions made by Michael Wilmink?
The percentage of profitable transactions made by Michael Wilmink is 80%.
What is the average return per transaction made by Michael Wilmink?
The average return per transaction made by Michael Wilmink is 66.40%.
What stocks does Michael Wilmink hold?
Michael Wilmink holds: TSE:EPRX stocks.
What was Michael Wilmink’s latest transaction?
Michael Wilmink latest transaction was an Informative Buy of C$5.14K.
What was Michael Wilmink's most profitable transaction?
Michael Wilmink’s most profitable transaction was an Informative Buy of TSE:EPRX stock on June 10, 2022. The return on the trade was 520.50%.
What is Michael Wilmink's role in Eupraxia Pharmaceuticals?
Michael Wilmink's role in Eupraxia Pharmaceuticals is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.